Lipocine Inc.LPCNNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+29.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+29.1%/yr
vs +1.3%/yr prior
Acceleration
+27.8pp
Accelerating
Percentile
P79
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 25.15% |
| Q3 2025 | -39.79% |
| Q2 2025 | -15.03% |
| Q1 2025 | -235.25% |
| Q4 2024 | 158.75% |
| Q3 2024 | 20.11% |
| Q2 2024 | -202.17% |
| Q1 2024 | 224.26% |
| Q4 2023 | 63.18% |
| Q3 2023 | -78.06% |
| Q2 2023 | 8.83% |
| Q1 2023 | -69.42% |
| Q4 2022 | 11.68% |
| Q3 2022 | 17.81% |
| Q2 2022 | -12.64% |
| Q1 2022 | -124.50% |
| Q4 2021 | 461.78% |
| Q3 2021 | -18.17% |
| Q2 2021 | 3.99% |
| Q1 2021 | 35.14% |
| Q4 2020 | -9.75% |
| Q3 2020 | -3.61% |
| Q2 2020 | 8.15% |
| Q1 2020 | -33.30% |
| Q4 2019 | -15.90% |
| Q3 2019 | 11.19% |
| Q2 2019 | -7.19% |
| Q1 2019 | 1.44% |
| Q4 2018 | -34.78% |
| Q3 2018 | 25.64% |
| Q2 2018 | -20.00% |
| Q1 2018 | 51.19% |
| Q4 2017 | -13.35% |
| Q3 2017 | 22.38% |
| Q2 2017 | -25.09% |
| Q1 2017 | -83.74% |
| Q4 2016 | 7.90% |
| Q3 2016 | 50.11% |
| Q2 2016 | 17.75% |
| Q1 2016 | -195.08% |